Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Sandra Gurrola | F | 57 | 3 years | |
| Mark Hensley | M | - | 8 years | |
| Stacy Wheeler | F | - | 8 years | |
| Noel Barnard | M | - | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark Leuchtenberger | M | 67 |
Eterna Therapeutics LLC
 Eterna Therapeutics LLC Pharmaceuticals: MajorHealth Technology Part of Eterna Therapeutics, Inc., Eterna Therapeutics LLC is a clinical-stage biopharmaceutical company based in New York, NY. The company is focused on exploring the role that cytokine-based therapy can have on the immune system in treating patients with cancer. Eterna Therapeutics is committed to developing irx-2, a novel cytokine-based therapy, to treat patients with cancer. The active constituents of irx-2, namely interleukin-2 (il-2) and other key cytokines, are postulated to signal, enhance and restore immune function suppressed by the tumor, thus enabling the immune system to attack cancer cells. Eterna Therapeutics is a late clinical-stage biopharmaceutical company focused on il-2 cytokine-based therapies in treating patients with cancer. Eterna Therapeutics was acquired by NTN Buzztime, Inc. on March 25, 2021 for $213.30 million.
IRX Therapeutics, Inc.
 IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | 2 years |
| Johnny Stilou | M | 57 | 8 years | |
| Mette Agger | F | 59 | 8 years | |
| Michael Heffernan | M | 59 | 5 years | |
| Howard Federoff | M | 71 | 1 years | |
| Luba Greenwood | F | 45 |
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | 1 years |
| John D. Weinberg | M | 57 | 6 years | |
| Ira Duarte | F | 55 | 7 years | |
| Alastair Stuart McEwan | M | 69 | 1 years | |
| Charles Cherington | M | 61 | 2 years | |
| Jay Sial | M | 60 | - | |
| Robert Radie | M | 60 | 4 years | |
| William Polvino | M | 63 | 6 years | |
| Paul Wotton | M | 63 | 4 years | |
| Kim Björnstrup | M | - | - | |
| Lars Kåre Viksmoen | M | 75 | - | |
| Dennis Langer | M | 73 | 1 years | |
| Craig Collard | M | 58 | 6 years | |
| Paul Edick | M | 67 | 3 years | |
| Erich Mohr | M | 70 | 1 years | |
| Kurt Anker Nielsen | M | 78 | 7 years | |
| Timothy Charles Melkus | M | 65 | - | |
| Edward Penhoet | M | 83 | 2 years | |
| Thomas Dyrberg | M | 69 | 13 years | |
| Srinivas Rao | M | 55 | 1 years | |
| Michelle McGuinness | F | - | - | |
| Lynn Sadowski Mason | F | 45 | 2 years | |
| Michael Gottlieb | M | 54 | - | |
| Jesse Shefferman | M | 52 | 3 years | |
| Susan Miller | F | 44 | - | |
| Richard Isaac Simtob | M | 54 | - | |
| Breian Knudsen | M | - | 9 years | |
| Kevin D'Amour | M | 51 | 1 years | |
| Alvin Shih | M | 47 | 2 years | |
| Jeff Paley | M | 55 | 1 years | |
| Yiannis A. Monovoukas | M | 62 | - | |
| Edward E. Koval | M | 62 | - | |
| Walter C. Ogier | M | 67 |
IRX Therapeutics, Inc.
IRX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology IRX Therapeutics, Inc. provides pharmaceutical products. Its therapies are designed to target and restore the immune system in order to improve a patient's response to next-generation cancer vaccines and novel targeted therapeutics. The company was founded in 1994 and is headquartered in New York, NY. | - |
| Allen Wolff | M | 52 | - | |
| Robert Dufour | M | - | - | |
| George Denny | M | - | - | |
| Nicholas Singer | M | 44 | - | |
| Maged Shenouda | M | 59 | - | |
| Roger Sidhu | M | 48 | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 24 | 50.00% |
| Denmark | 24 | 50.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronald Guido
- Personal Network
